Conducting Clinical Trials Part 5: Confidentiality Issues

Clinical trials have found their way into the spotlight of the coronavirus pandemic as multiple pharmaceutical and biotechnology companies race to develop and market vaccines and therapies. As breakthrough technologies are on the rise, so are the risks associated with vaccine and drug development. “Conducting Clinical Trials” is a podcast miniseries featuring Choate attorneys covering a number of topics related to clinical trials, including common mistakes companies make along the way and various strategic choices they face.

Clinical trial data can be among the most sensitive data held by a life sciences company. Despite contractual confidentiality provisions, there are many entities and organizations that would like to obtain access to information that would otherwise be confidential related to clinical trials. In the fifth and final episode of Choate’s Conducting Clinical Trials series, Julia Hesse and Danielle Pelot analyze confidentiality issues that can arise with clinical trial information and provide cautionary takeaways for when sponsors (life sciences companies) are planning and working with sites in structuring trials. 

 Listen to additional episodes →